HIV Infection Increases Risk of ASCUS and Subsequent Development of SILs Slideset on: Duerr A, Paramsothy P, Jamieson DJ, et al. Effect of HIV infection.

Slides:



Advertisements
Similar presentations
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
Advertisements

Repositioning Prevention and Control of Cancers of Reproductive Organs in Kenya Repositioning Prevention and Control of Cancers of Reproductive Organs.
Clinical Use of HPV DNA Testing Thomas C. Wright, Jr. College of Physicians and Surgeons of Columbia University.
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Updates on Pap Smear Guidelines 2014
Speaker: Decca Mohammed, MD.  Statistics for cervical cancer and HPV  Association of HPV to cervical cancer, and other cancers  Prevention  Screening.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Prevalence of anal Human Papillomavirus (HPV) infection and anal squamous intraepithelial.
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
Case Presentations: Pre-Invasive Cervical Neoplasia
Patients in routine HIV clinical care at-risk for potentially transmitting HIV in the “test and treat” era of HIV prevention Crane, HM, Mimiaga, M, Feldman,
Cervical Cancer Screening
Screening Tests for Brest & Cervical Cancer
Cervical Cancer in California Janet Bates, MD MPH Research Program Director Research and Surveillance Program California Cancer Registry.
Reproductive Health Needs of Men and Women Enrolled in HIV Care and Treatment Services Elaine Abrams August 12, 2008 Track 1.0 Meeting.
The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected Persons The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students R.L. Winer, Shu-Kuang Lee, J.P. Hughes, D.
Fatal and Non-fatal Hepatic Failure in HIV-infected versus HIV-uninfected Persons Enrolled in Kaiser Permanente California (KP), a Large Managed Care Organization.
Current guidelines for Cervical Cancer Screening
Management and Development for Health (MDH)
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Cervical Intraepithelial Neoplasm
HIV/renal studies (CHIC) Baseline renal function as predictor of HIV/renal disease progression –Death, opportunistic infection –Severe chronic kidney disease.
Impact of Highly Active Antiretroviral Therapy on the Incidence of HIV- encephalopathy among perinatally- infected children and adolescents. Kunjal Patel,
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
Transplantation in HIV Michelle Roland, MD Assistant Professor of Medicine UCSF Positive Health Program at SFGH.
Dr. Phimpha Paboriboune, Scientific Director,
Cervical Cancer Screening and Sexually Transmitted Infection Case Study PCP version
Strategies for Management of Antiretroviral Therapy Study Wafaa El-Sadr and James Neaton for the SMART Study Team.
Grinsztejn B, et al, Lancet Infect Dis, March 4 th 2014 PRIMARY COMBINED M&M OUTCOME FIRST AIDS DEFINING EVENT FIRST TB EVENT DEATH.
Weekly Alendronate Safe and Effective at Increasing Bone Mineral Density in HIV-Infected Persons on Antiretroviral Therapy Slideset on: McComsey GA, Kendall.
Paz Bailey G 1, Sternberg M 1, Puren AJ 2, Markowitz LE 1, Ballard R 1, Delany S 3, Hawkes S 4, Nwanyanwu O 1, Ryan C 1, and Lewis DA 5 1. NCHHSTP, CDC.
Effect of ART on malaria parasitaemia and clinical episodes in adults in rural Uganda: A population-based cohort study Billy N. Mayanja 1, Kathy Baisley.
Slideset on: Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the.
Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
Neurologic Effects Associated With Efavirenz Generally Mild, Transient Slideset on: Clifford DB, Evans S, Yang Y, et al. Impact of efavirenz on neuropsychological.
Efavirenz Use Not Associated With Depressive Episodes, According to Analysis of Randomized Clinical Trial Outcomes Slideset on: Journot V, Chene G, De.
HPV-related anogenital cancers
Identification of Potential Risk Factors for Mother-to- Infant HCV Transmission Slideset on: Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal.
Previous SVR With Interferon-Based Therapy for HCV Lowers Risk of Hepatotoxicity in HIV/HCV-Coinfected Individuals on Antiretroviral Therapy Slideset on:
POWER 3 Study Confirms Safety and Efficacy of Darunavir/Ritonavir in Treatment-Experienced Patients Slideset on: Molina JM, Cohen C, Katlama C, et al.
Cytopathology Feb
Reducing Tobacco Intake Lowers Risk of Lung Cancer in Heavy Smokers Slideset on: Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung.
Effects of Alcohol and Crack Cocaine Use on Virological and Immunological Disease Progression in a Cohort of U.S. Women with HIV/AIDS Judith A. Cook, Ph.D.
Slideset on: Emery S, Neuhaus JA, Phillips AN, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving.
Improving Patients Retention in Antiretroviral Treatment Programs: The experience of ARV Programs in Côte d’Ivoire Eugène MESSOU, MD, PhD CePReF- Aconda.
ACTG 5142: First-line Antiretroviral Therapy With Efavirenz Plus NRTIs Has Greater Antiretroviral Activity Than Lopinavir/Ritonavir Plus NRTIs Slideset.
First-Line Treatment of HIV Infection With Either NNRTI- or PI-Based Regimens Effective for Long-term Disease Control Slideset on: MacArthur RD, Novak.
Tipranavir/Ritonavir Superior to Comparator PI/Ritonavir at Week 48 in Multiclass-Experienced Patients Slideset on: Hicks CB, Cahn P, Cooper DA, et al.
Adefovir Suppresses HBV DNA Levels in Lamivudine-Resistant HIV/HBV Patients Slideset on: Benhamou Y, Thibault V, Vig P, et al. Safety and efficacy of adefovir.
Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions ELINA VIRTANEN1, ILKKA KALLIALA2,3,
No conflicts of interest
Cervical Cancer in California
Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern.
Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women.
HPV-Related Disease: Separating Fact From Fiction
Volume 5, Issue 1, Pages e45-e58 (January 2018)
Management and Development for Health (MDH)
Cervical Screening for Dysplasia and Cancer in Patients with HIV
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis  Chunqing Lin,
Volume 153, Issue 1, Pages (April 2019)
Fig. 2. Three cervical screening strategies to detect CIN2+/CIN3+
Presentation transcript:

HIV Infection Increases Risk of ASCUS and Subsequent Development of SILs Slideset on: Duerr A, Paramsothy P, Jamieson DJ, et al. Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis. 2006;42:

clinicaloptions.com/hiv HIV Infection Increases Risk of ASCUS and Subsequent Development of SILs Duerr A, et al. Clin Infect Dis. 2006;42: Background and Rationale  Atypical squamous cells of undetermined significance (ASCUS) etiology and outcome uncertain  Management guidelines vary according to patient’s HIV status, likelihood of developing high-grade squamous intraepithelial lesions (SILs)  Unknown whether current guidelines for HIV-infected women optimal, given uncertain significance between ASCUS, cervical intraepithelial neoplasia  Current study compared prevalence, characteristics, and risks associated with ASCUS between HIV-infected and HIV-uninfected women

clinicaloptions.com/hiv HIV Infection Increases Risk of ASCUS and Subsequent Development of SILs Duerr A, et al. Clin Infect Dis. 2006;42: Summary of Study Design  HIV-infected and at-risk, HIV-uninfected women enrolled in 4 US cities between April 1993 and January 1995  Pap tests, gynecologic exams, Gram stains, HPV testing, and HIV-1 testing performed at each semiannual visit –2 sites referred for colposcopy if Pap test showed SILs or 2 consecutive Pap tests showed ASCUS; other site routinely performed colposcopy at each visit –For HIV-infected women, HIV-1 RNA, CD4+ cell count, and self-reported antiretroviral use determined  ASCUS cumulative incidence estimated using product- limit survival estimator; median follow-up: 4.4 years

clinicaloptions.com/hiv HIV Infection Increases Risk of ASCUS and Subsequent Development of SILs Duerr A, et al. Clin Infect Dis. 2006;42: Baseline Characteristics  N = 1199; 795 HIV-infected, 404 at-risk, HIV-uninfected  Compared with HIV-uninfected women, HIV-infected women: –More likely to be black –Less likely to have completed high school –More likely to use condoms within 6 months prior to enrollment –Less likely to use crack within 6 months prior to enrollment –Less likely to have > 1 male sexual partner within 6 months prior to enrollment

clinicaloptions.com/hiv HIV Infection Increases Risk of ASCUS and Subsequent Development of SILs Duerr A, et al. Clin Infect Dis. 2006;42:  Pap test data for 10 semiannual visits (up to 4.7 years) included in analysis; included 8185 Pap tests  ASCUS characteristics generally comparable between HIV-infected and HIV-uninfected women  HIV-infected women more likely than HIV-negative women to be coinfected with HPV (58% vs 24%; P <.01)  HIV-infected women more likely to have high-risk HPV infection (23% vs 14%; P <.01)  HIV-infected women more likely to have Candida vaginal infection (37% vs 28%; P <.01) Main Findings

clinicaloptions.com/hiv HIV Infection Increases Risk of ASCUS and Subsequent Development of SILs Duerr A, et al. Clin Infect Dis. 2006;42:  Factors significantly associated with ASCUS in all women: –HIV infection –Cumulative incidence in women with normal Pap at enrollment, 78% in HIV-infected women vs 38% in HIV-uninfected women (P <.01) –Presence of cervical ectopy, HPV risk type, black race, Pap results at last visit  CD4+ cell count < 200 cells/mm 3 significantly associated with ASCUS in HIV-infected women Risk Factors for Developing ASCUS

clinicaloptions.com/hiv HIV Infection Increases Risk of ASCUS and Subsequent Development of SILs Duerr A, et al. Clin Infect Dis. 2006;42: Risk Factors for ASCUS, Progression of ASCUS to SILs Characteristic Adjusted HR (95% CI) for ASCUS All Women (n = 701) HIV-Infected Women (n = 426) All Women (n = 196) HIV-Infected Women (n = 148) HIV infected1.8 ( )--2.4 ( )-- CD4+ cell count < 200 cells/mm ( )--1.7 ( ) HPV risk type  High/intermediate3.2 ( )3.1 ( )2.4 ( )2.4 ( )  Low/untypeable1.6 ( )1.8 ( )1.6 ( )1.6 ( ) Positive Candida culture1.3 ( )1.4 ( )--

clinicaloptions.com/hiv HIV Infection Increases Risk of ASCUS and Subsequent Development of SILs Duerr A, et al. Clin Infect Dis. 2006;42: Key Conclusions  HIV-infected women more likely to develop ASCUS based on Pap results than HIV-uninfected women –HIV-infected women with low CD4+ cell count particularly at risk  HIV-infected women with ASCUS more likely to progress to develop SILs than HIV-uninfected women –Those with low CD4+ cell count particularly at risk  Findings indicate that current guidelines recommending colposcopy for HIV-infected women with ASCUS appropriate